Skip to main content
. 2021 Apr 19;11:8485. doi: 10.1038/s41598-021-87792-w

Table 3.

Conflicting interpretations of pathogenicity.

BRCA1 RS_number (Likely) Pathogenic Uncertain significance (Likely) Benign No. of patients OR CI

c.1357G>C,

p.Glu453Gln

rs768054411 3 1 1

c.154C>T

p.Leu52Phe

rs80357084 5 3 15 0.4646 0.2421–0.8914

c.2481A>C

p.Glu827Asp

rs397508970 2 1 1 0.7082 0.0446–11.2359

c.2726A>T

p.Asn909Ile

rs80357127 8 1 2

c.4729T>C

p.Ser1577Pro

rs80356909 1 7 9 1.2874 0.4314–3.8417

c.5014_5016delCAC

p.His1673del

rs80358343 3 4 1

c.5068A>C

p.Lys1690Gln

rs397507239 8 1 1 0.2358 0.0246–2.2601

c.5332G>A

p.Asp1778Asn

rs80357112 2 3 1

c.5339T>C

p.Leu1780Pro

rs80357474 4 1 12 8.5181 1.1192–64.8277

c.547 + 14delG

c.547 + 14delG

rs273902771 2 4 6

c.671-8A>G

c.671-8A>G

rs80358144 1 4 5 0.8852 0.2385–3.2849

c.811G>A

p.Val271Met

rs80357244 1 11 2 0.3537 0.065–1.9254
BRCA2 RS_number (Likely) Pathogenic Uncertain significance (Likely) Benign No. of patients OR CI

c.10150C>T

p.Arg3384Ter

rs397507568 1 5 2 0.4717 0.0791–2.8122

c.1568A>G

p.His523Arg

rs80358443 2 9 2 0.2855 0.0554–1.4714

c.1817C>T

p.Pro606Leu

rs80358469 5 1 1 0.7145 0.0448–11.4046

c.182T>C

p.Leu61Pro

rs1555280374 2 1 1
c.1909 + 22delT rs276174816 1 7 1
c.317-10A>G rs81002824 1 1 1

c.3256A>G

p.Ile1086Val

rs80358571 5 2 3

c.4599A>C

p.Lys1533Asn

rs80358694 3 5 1

c.5554G>A

p.Val1852Ile

rs80358777 4 2 1 0.7078 0.0446–11.225

c.5969A>C

p.Asp1990Ala

rs148618542 6 1 7 1.2391 0.3642–4.216

c.6101G>A

p.Arg2034His

rs80358849 2 1 1

c.6131G>T

p.Gly2044Val

rs56191579 1 8 4 0.4078 0.1194–1.3933

c.6325G>A

p.Val2109Ile

rs79456940 2 10 10 0.6488 0.2754–1.5285

c.7522G>A

p.Gly2508Ser

rs80358978 7 6 9 0.5353 0.2254–1.2713

c.8092G>A

p.Ala2698Thr

rs80359052 6 4 1

c.8486A>G

p.Gln2829Arg

rs80359100 2 1 1
c.8954-5A>G rs886040949 5 1 1

c.964A>C

p.Lys322Gln

rs11571640 3 9 4 0.2375 0.0766–0.7367